split-banner-image

Breast MRI Evaluation

Closed

BCT 2001: Breast MRI Evaluation

BCT Study Chair:

Christobel Saunders

The Breast MRI Study aims to find out the best way to use breast Magnetic Resonance Imaging (MRI) and if it will improve treatment options and patient outcomes, in women recently diagnosed with breast cancer.

INTERNATIONAL

N/A

INTERNATIONAL

Total number of trial

participants internationally

AUSTRALIA & NEW ZEALAND

406

AUSTRALIA & NEW ZEALAND

Total number of trial participants

in Australia and New Zealand

INSTITUTIONS

7

INSTITUTIONS

Total number of participating institutions

in Australia and New Zealand

BREAST MRI EVALUATION PUBLICATIONS

2022

Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy—a sub-analysis of the ALTTO study.

Nader-Marta G, Debien V, Eiger D, Tsourti Z, Caparica R, Kassapian M, Napoleone S, Hultsch S, Korde L, Wang Y, Chumsri S, Pritchard K, Untch M, Bellet-Ezquerra M, Dornelles Rosa D, Moreno-Aspitia A, Piccart M, Dafni & de Azambuja E. British Journal of Cancer. 2022; 1271799 – 1807, Published online 01 September 2022, Journal

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.

Geyer CE, Garber JE, Gelber RD, Yothers et al. and the OlympiA Clinical Trial Steering Committee and Investigators. Annals of Oncology. 2022; 33(12):1250 – 1268, Journal